$PODD — WATCHLIST 📊

$PODD — WATCHLIST 📊 Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. 🎯 Q2 2026 | Rev $1B | EPS $1.42 vs $1.19 🟢 💡 Consensus expected modest earnings, but the beat may not be fully priced if the market is overly focused on macro headwinds or competitive threats. The variant view is that estimate revisions will accelerate, revealing undervaluation. 📉 Reward/Risk: 1.67:1 🏢 Business Quality: 7/10/10 - Leader in tubeless insulin delivery with recurring revenue and high switching costs; however, faces competitive pressure from Medtronic, Tandem, and new entrants, and reimbursement risks. 📊 Our read: WATCHLIST. Full analysis → https://stockduty.xyz/s/PODD0622 Also in play: $TNDM $DXCM $ABT $MDT $EW $ROG

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.